Vimarsana
Biggest News Aggregation in the World

Sleepx Pro News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sleepx Pro. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sleepx Pro Today - Breaking & Trending Today

AppYea Announces Appointment of Leading Medical Device Industry Executive ... - Vimarsana News

AppYea Announces Appointment of Leading Medical Device Industry Executive ...

AppYea Announces Appointment of Leading Medical Device Industry Executive ...

DGAP-News: SleepX approved by the Helsinki Committee to conduct clinical trial with the SleepX PRO smartphone application - Vimarsana News

DGAP-News: SleepX approved by the Helsinki Committee to conduct clinical trial with the SleepX PRO smartphone application

DGAP-News: Appyea SleepX approved by the Helsinki Committee to conduct clinical trial with the SleepX PRO smartphone application 31.05.2022 / 14:30 The issuer is solely responsible for the content of this announcement. SleepX, a subsidiary of AppYea (OTC: APYP) focusing on the development of acc...

SleepX approved by the Helsinki Committee to conduct clinical trial with the SleepX PRO smartphone application - Vimarsana News

SleepX approved by the Helsinki Committee to conduct clinical trial with the SleepX PRO smartphone application

SleepX PRO is designed to diagnose sleep apnea using only a smartphone. The trial will be conducted at Soroka Hospital (IL) and will include up to 150 subjects.

DGAP-News: Appyea: SleepX approved by the Helsinki Committee to conduct clinical trial with the SleepX PRO smartphone application - Vimarsana News

DGAP-News: Appyea: SleepX approved by the Helsinki Committee to conduct clinical trial with the SleepX PRO smartphone application

DGAP-News: Appyea SleepX approved by the Helsinki Committee to conduct clinical trial with the SleepX PRO smartphone application 31.05.2022 / 14:30 The issuer is solely responsible

Roundup: PocDoc secures CE mark for lateral flow testing, Poolbeg Pharma and CytoReason partner, and more briefs - Vimarsana News

Roundup: PocDoc secures CE mark for lateral flow testing, Poolbeg Pharma and CytoReason partner, and more briefs

Also, Caterpillar receives £450,000 for rewards-based digital health platform.